• Explore /
  • Poster
  • / Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC).

Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC).

Abstract Poster

Authors

Arjun Balar

Arjun Vasant Balar

Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY

Arjun Vasant Balar , Gopa Iyer , Matthew I. Milowsky , William C. Huang , Michael Woods , S. Machele Donat , Harry W. Herr , Guido Dalbagni , Bernard H. Bochner , Irina Ostrovnaya , Hikmat Al-Ahmadie , Tracy Lynn Rose , Jamie Cathleen Riches , Brooke Elizabeth Kania , Ashley Marie Regazzi , Asia S. McCoy , Daniela Delbeau , Jonathan E. Rosenberg , Dean F. Bajorin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT01589094

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 436)

DOI

10.1200/jco.2016.34.2_suppl.436

Abstract #

436

Poster Bd #

J7

Abstract Disclosures

Similar Posters

First Author: Elizabeth R. Plimack

First Author: Shilpa Gupta

First Author: Arjun Vasant Balar

First Author: Elizabeth R. Plimack